3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
Paclitaxel
79
Cisplatin
72
Carboplatin
72
Bevacizumab
29
Radiotherapy
27
Brachytherapy
23
Hyperthermic Intraperitoneal Chemotherapy
20
Drug Therapy
20
olaparib
19
Gemcitabine
17
niraparib
16
apatinib
16
pembrolizumab
15
Surgical Procedures, Operative
15
liposomal doxorubicin
12
Cyclophosphamide
12
Surveys and Questionnaires
11
camrelizumab
10
Taxes
10
Neoadjuvant Therapy
10
fludarabine
9
anlotinib
9
Etoposide
9
Blood Specimen Collection
9
Topotecan
8
Docetaxel
8
Sentinel Lymph Node Biopsy
7
Platinum
7
Injections
7
Cytoreduction Surgical Procedures
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Diffusion
×
Gynecologic
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled